Pachamuthu Kandasamy

This inventor holds 33 USPTO granted patents and 30 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Oligonucleotide Synthesis. Top assignees: Alnylam Pharmaceuticals, Inc., Wave Life Sciences Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pachamuthu Kandasamy. Retrieved from https://idiyas.com/inventor/pachamuthu-kandasamy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 30)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 31)

EPO Patents = 3 (Patent Applications = 34)

Average Co-Inventor Count = 7.7

ph-index = 8

Forward Citations = 151(Granted Patents)

Location History:

Malden, MA (US) (2015)
Cambridge, MA (US) (2018 - 2024)
Belmont, MA (US) (2023 - 2024)

Company Filing History:

22 out of 466

Alnylam Pharmaceuticals, Inc.

patents

11 out of 41

Wave Life Sciences Ltd.

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Oligonucleotide Compositions

Biodegradable Lipids

RNA Agents

Phosphoramidite Synthesis

Multi-Targeted Conjugates

Oligonucleotide-Ligand Conjugates

Active Agent Delivery

Chemical Synthesis

Conjugate Preparation

Carbohydrate Conjugates

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760305 - OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF (2026-10-13),

2. 12653893 - Carbohydrate conjugated RNA agents and process for their preparation (2026-06-16),

3. 12590115 - TECHNOLOGIES USEFUL FOR OLIGONUCLEOTIDE PREPARATION (2026-03-31),

4. 12552743 - Oligonucleotide compositions and methods of use thereof (2026-02-17),

5. 12473321 - COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS (2025-11-18),

6. 12435105 - Technologies for oligonucleotide preparation (2025-10-07),

7. 12428442 - Compounds, compositions and methods for synthesis (2025-09-30),

8. 12391942 - Oligonucleotide compositions and methods of use thereof (2025-08-19),

9. 12364762 - Biodegradable lipids for the delivery of active agents (2025-07-22),

10. 12350338 - Biodegradable lipids for the delivery of active agents (2025-07-08),

11. 12343398 - Biodegradable lipids for the delivery of active agents (2025-07-01),

12. 12239709 - Biodegradable lipids for the delivery of active agents (2025-03-04),

13. 12221607 - Multi-targeted single entity conjugates (2025-02-11),

14. 12173288 - Oligonucleotide-ligand conjugates and process for their preparation (2024-12-24),

15. 11944687 - Carbohydrate conjugate RNA agents and process for their preparation (2024-04-02),

Title: The Innovative Journey of Inventor Pachamuthu Kandasamy

Introduction:

Pachamuthu Kandasamy, a visionary inventor based in Cambridge, MA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Kandasamy's recent patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, smart home technology, and renewable energy solutions.

Career Highlights:

With a background in computer science and engineering, Kandasamy has a proven track record of developing innovative solutions that have revolutionized various industries. His work has been recognized globally for its impact and ingenuity.

Collaborations:

Throughout his career, Kandasamy has collaborated with leading tech companies, research institutions, and universities to further enhance his inventions and bring them to market. His collaborative spirit has led to the successful implementation of cutting-edge technologies in real-world applications.

Conclusion:

Inventor Pachamuthu Kandasamy's relentless pursuit of innovation and his passion for creating transformative technologies continue to inspire the next generation of inventors and entrepreneurs. His contributions to the world of technology are truly remarkable and have left an indelible mark on the industry.

Profile summary based on public USPTO records.